Background: Pre-diabetes is considered to be an important reversible stage of type 2
Family history of diabetes, age, obesity, smoking, alcoholism, hypertension, and hyperlipidaemia have been confirmed as important predictors of T2DM. 4 In recent years, many researches have proposed markers of low-grade inflammatory can be used as an early predictor of T2DM. 5, 6 As one of the markers of low-grade inflammatory, white blood cell (WBC) is widely used in the evaluation of inflammation and metabolic related diseases because of its ease of monitoring and identification. [7] [8] [9] Recently, studies have shown WBC counts as an independent risk marker for IR, diabetes, metabolic syndrome (MetS), or coronary artery disease (CAD). [10] [11] [12] Especially for over a decade, cross-sectional studies have been
showing that there is a close relationship between WBC and the prevalence of IFG or T2DM. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] But only a few follow-up studies on the risk of WBC and IFG or T2DM count have been conducted, such as Nakanishi et al. Study
showed high-level WBC can predict the progression of IFG or T2DM, especially in nonsmokers followed for 7 years. 4 However, the followup population is Japanese office workers male, which is not suitable for the Chinese community. At the same time, there is a certain limitation in not considering the female group when discussing this association. Other prospective studies have also shown a close relationship between WBC and the prevalence of IFG or T2DM. 23, 24 However, these studies usually involve relatively few subjects, and the subjects are not representative. Our study included men and women between the ages of 20 and 70, while Tanigawa et al included only middle-aged men. 25 Therefore, we used a prospective correlation study design to observe the incidence of IFG at different WBC counts during followup, further determine the impact of WBC on IFG, and further identify the risk indicators for predicting prediabetes.
In summary, this study initially conducted a cross-sectional analysis of the population who underwent physical examination to explore the relationship between WBC count and fasting blood glucose (FBG) levels. Then, a follow-up study was conducted on the population that underwent IFG normal physical examination to explore the relationship between baseline WBC count and changes in FBG levels and the cumulative risk of 6-year IFG. 3 | METHODS
| PATIENTS AND METHODS

| Patients
| Data collection
Measurement of height, weight, and blood pressure (BP) was conducted by professional staff.
Height and weight were measured in patients wearing light clothing and without shoes. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters. BP was measured by trained doctors using a mercury sphygmomanometer on the dominant arm after a resting period of at least 5 minutes in the supine position. The patient's arm was placed at the heart level,
and BP values were taken as the mean of three measurements.
| Questionnaire survey
The general condition, sex, age, past history, family history, alcohol and tobacco hobbies, and medications in the past 6 months were obtained by qualified physicians and researchers and were recorded on the unified design form. All staff were intensively trained to standardize operational procedures and methods prior to the study. Questionnaires were used to obtain the demographic data (sex, age, etc), past medical history (cardiovascular disease, hypertension, diabetes, etc), as well as smoking status, drinking status, income status, and education level.
| Assessment of biomarkers and covariates
The following biomarkers were measured in all participants: WBC, red blood cell (RBC), haemoglobin (Hgb), platelet (PLT), FBG, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), total protein (TP), serum creatinine, serum uric acid (SUA), aspartate aminotransferase (AST), and alanine aminotransferase (ALT). A venous blood sample was drawn from all patients after an overnight fast (at least 10 h) and allowed to clot at room temperature for 1 to 3 hours. Immediately after clotting, the serum was separated by centrifugation for 15 minutes at 3000 rpm (centrifugal radius one-fourth 11 cm). All biochemical assays were determined enzymatically using an autoanalyser (Type 7600, Hitachi Ltd, Tokyo, Japan).
| Statistical analysis
Data management and statistical analysis were performed using SPSS version 17.0. All hypothesis tests were performed using a two-tailed test. Measured data were expressed as means ± standard deviation ( Figure 1) , and the trend was considered significant (P = 0.032) ( Table 1 and Supplement Table 2 (supplementary material online).
| DISCUSSION
This study found that as the number of follow-up years increased, the risk of IFG increased with increasing baseline WBC. This finding is consistent with those reported in previous studies conducted in Asian Indians 28 and Japanese. 4 In addition, we found that this association persisted after adjusting for risk factors known for possible changes in glucose status (age, obesity, history of hypertension, family history of diabetes, history of dyslipidaemia, and smoking, drinking. These Abbreviations: IFG: impaired fasting glucose; WBC: white blood cell.
FIGURE 1
The cumulative incidence of IFG of four categories of percent WBC during follow-up period (IFG: impaired fasting glucose; WBC: white blood cell count) Our results are consistent with those reported in previous large prospective cohort studies. 29, 30 These previous studies have found that obesity can lead to low-grade chronic inflammation in the body, which resulted in the development of metabolic disorders and complications. 7 Finally, the relationship between elevated WBC count and hypertension reported in previous studies 31, 32 was not observed in this study. history, and comorbidities, cannot be properly adjusted because the baseline data obtained through the questionnaire were incomplete.
The existence of these problems may have an impact on the results.
In summary, we found that in the Chinese population, even if the WBC count is within the normal range, increase in circulating WBC count is positively correlated with the risk of IFG regulation. Therefore, our study concluded that the elevation of WBC counts may indicate a higher risk of developing IFG and T2DM. Finally, combined with the results of our study, we know that WBC count is also related to BMI, smoking, TGs, LDL levels, HDL levels. Therefore, weight control, early smoking cessation, and lipid-lowering treatments are needed to improve chronic low-grade inflammation. It can also help prevent prediabetes and T2DM by detecting WBC counts.
